Qlife Holding Valuation

Is QLIFE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of QLIFE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate QLIFE's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate QLIFE's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for QLIFE?

Key metric: As QLIFE barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for QLIFE. This is calculated by dividing QLIFE's market cap by their current book value.
What is QLIFE's PB Ratio?
PB Ratio	35.3x
Book	SEK 199.00k
Market Cap	SEK 6.98m

QLIFE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	181.7x
Enterprise Value/EBITDA	-0.2x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does QLIFE's PB Ratio compare to its peers?

The above table shows the PB ratio for QLIFE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	2.2x
CALMA B Calmark Sweden	0.3x	n/a	SEK 11.0m
2CUREX 2cureX	3.2x	n/a	SEK 8.6m
ALTE Alteco Medical	4x	n/a	SEK 21.4m
EVOL Evolear	1.4x	n/a	SEK 2.2m
QLIFE Qlife Holding	35.3x	n/a	SEK 7.0m

Price-To-Book vs Peers: QLIFE is expensive based on its Price-To-Book Ratio (35.3x) compared to the peer average (2.2x).

Price to Book Ratio vs Industry

How does QLIFE's PB Ratio compare vs other companies in the SE Medical Equipment Industry?

5 Companies	Price / Book	Estimated Growth	Market Cap
MEDF Medfield Diagnostics	0.3x	n/a	US$2.17m
BRIG Brighter	0.1x	n/a	US$2.23m
CALMA B Calmark Sweden	0.3x	n/a	US$1.08m
S2M S2Medical	0.3x	n/a	US$223.47k

5 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: QLIFE is expensive based on its Price-To-Book Ratio (35.3x) compared to the Swedish Medical Equipment industry average (2.3x).

Price to Book Ratio vs Fair Ratio

What is QLIFE's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

QLIFE PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	35.3x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate QLIFE's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Iconovo

SEK 80.5m

Develops and licenses inhalation medications in Sweden.

ICO

SEK 5.06

-0.8%

-45.4%

Dignitana

SEK 99.1m

A medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally.

DIGN

SEK 1.23

11.8%

-42.8%

Mentice

SEK 583.0m

Provides endovascular simulation technology solutions in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas.

MNTC

SEK 22.80

8.6%

-44.7%